Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
112 <strong>Annual</strong> Financial Statement Konzern-Jahresabschluss<br />
3.13. Retrospective adjustment due to error correction pursuant to IAS 8<br />
Inventories as well as produced assets were not assessed pursuant to IAS 2 in the previous periods.<br />
Due to the correction of this error the figures of the consolidated annual financial statement of 30 June<br />
<strong>2009</strong> as well as the opening balance of this financial statement of 1 July 2008 were adjusted as follows.<br />
The adjustment of the opening balance affected the following assets:<br />
Adjustment of<br />
balance sheet item<br />
and balance sheet<br />
totals<br />
July 1, 2008<br />
Before<br />
adjustment<br />
Amount of<br />
adjustment<br />
Reason of<br />
adjustment<br />
July 1, 2008<br />
After<br />
adjustment<br />
Euro<br />
Euro<br />
Euro<br />
Property, plant and equipment<br />
7,950,181 (110,000) 1. 7,840,181<br />
Machinery and technical<br />
equipment<br />
2,580,469 (110,000) 1. 2,470,469<br />
Deferred taxes 2,551,834 226,734 3. 2,778,568<br />
Total non-current assets 19,220,845 116,734 5. 19,337,579<br />
Inventories 24,066,539 (632,659) 2. 23,433,880<br />
Finished goods and goods<br />
for resale<br />
17,568,333 (632,659) 2. 16,935,674<br />
Current assets 47,428,213 (632,659) 2. 46,795,554<br />
Total assets 66,649,058 (515,925) 5. 66,133,133<br />
Retained earnings / Accumulated<br />
income<br />
5,518,502 (515,925) 4. 5,002,577<br />
Equity attributable to<br />
shareholders of the parent<br />
entity<br />
52,292,358 (515,925) 4. 51,776,433<br />
Total shareholders‘ equity 52,501,410 (515,925) 4. 51,985,485<br />
Total liabilities and shareholders‘<br />
equity<br />
66,649,058 (515,925) 5. 66,133,133<br />
The adjustment was done due to the following discoveries and circumstances:<br />
1. Within technical equipment and machines the unrealized profit on previously activated capitalized<br />
machines has been adjusted. The correction was done at the expense of the retained earnings.<br />
2. The stock-in-trade for previously activated finished goods applied to the unrealized profit was corrected<br />
to the amount of KEUR -2,290. They comprise of KEUR -1,246 for finished goods recognized as<br />
stock-in-trade and KEUR -1,044 unrealized profit for internally generated assets which previously had<br />
been deducted and neutralized within the stock-in-trade. A correction due to an evaluation pursuant to<br />
IAS 2 of the inventories on 1 July 2008 and which had been evaluated as partial costs (KEUR 1,657) had<br />
an opposing effect. Overall corrections total to KEUR -632 stock-in-trade.<br />
3. The correction of deferred taxes results from the overall corrections of the stock-in-trades and fixed<br />
assets. The passive latencies arise from re-evaluations of CeramOptec GmbH’s stock-in-trades pursuant<br />
to IAS 2. They were offset against <strong>biolitec</strong>’s active latencies from debit carryover due to the interlocking<br />
relationship between CeramOptec and <strong>biolitec</strong>. Therefore they have been recognized as “Deferred Taxes<br />
– Assets” after balancing with the active latencies from the consolidation of equity.<br />
4. The correction of stock-in-trade, fixed assets and deferred taxes effect the profit/loss carried forward<br />
and therefore the equity to the amount of KEUR -516.